Characterization of Candida Species Isolated from Cases of Lower Respiratory Tract Infection among HIV/AIDS Patients in Calabar, Nigeria

DOI: 10.4236/wja.2013.33027   PDF   HTML     5,142 Downloads   7,885 Views   Citations

Abstract

This study was designed to identify and characterize the Candida species isolated from lower respiratory tract infections among HIV positive patients and to determine the prevalence rates of Candida infections among these subjects. Two early morning expectorate sputum samples were collected from 272 HIV positive subjects visiting the ART clinics and DOTS centre with cases of lower respiratory tract infection, over a period of 14 months from May 2009 to July 2010 in Calabar. Subjects were recruited for this study upon approval by the Ethical Research Committee of the University of Calabar Teaching Hospital and obtaining written informed consent from the patients. Samples were processed by standard methods for isolation of Candida. Speciation was done by a germ tube test, chlamydospore production on corn meal agar and sugar fermentation and assimilation tests using the Microexpress Candida identification kit (Tulip, India). Out of the 544 sputum samples collected from 272 subjects, Candida species were isolated from 40 (14.7%) and identified after confirming the growth in the second sample. The majority of Candida species among the Candida isolates were Candida albicans (80%) followed by Candida tropicalis 5 (12.5%), Candida dubliniensis 2 (5.0%) and Candida guilliermondii 1 (2.5%). The isolation rate of Candida species from sputum samples was found to be highest among subjects aged 25 - 34 years, followed by those aged 15 - 24 years. Twenty (7.3%) HIV seropositive subjects had bacterial infections, while 4 (1.5%) subjects had mixed fungal and bacterial infections. This study is the first of its kind to be carried out in Calabar and the South-South geopolitical region of Nigeria, and has shown that pulmonary candidiasis is a health problem among HIV positive patients in Calabar.

Share and Cite:

O. Ogba, L. Abia-Bassey, J. Epoke, B. Mandor and G. Iwatt, "Characterization of Candida Species Isolated from Cases of Lower Respiratory Tract Infection among HIV/AIDS Patients in Calabar, Nigeria," World Journal of AIDS, Vol. 3 No. 3, 2013, pp. 201-206. doi: 10.4236/wja.2013.33027.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] A. Chakrabati and M. R. Shivaprakash, “Microbiology of Systemic Fungal Infections,” Journal of Postgraduate Medicine, Vol. 51, No. 5, 2005, pp. 16-20.
[2] R. A. Calderone and W. A. Fronzi, “Virulence of Candida albicans,” Trends in Microbiology, Vol. 9, No. 7, 2001, p. 327. doi:10.1016/S0966-842X(01)02094-7
[3] B. K. Jha, S. Dey, M. D. Tamang, M. E. Joshy, P. G. Shivananda and K. N. Brahmadatan, “Characterization of Candida Species Isolated from Cases of Lower Respiratory Tract Infection,” Kathmandu University Medical Journal, Vol. 4, No. 3, 2006, pp. 290-294.
[4] E. Segal and D. Elad, “Candidiasis,” In: W. M. Scheld, D. C. Hooper and J. M. Hughes, Eds., Topley and Wilson’s Microbiology and Microbial Infections, 10th Edition, Hodder Arnold ASM Press, Washington DC, 2005, pp. 479-623.
[5] D. R. Soll, “Candida and Virulence: The Evolution of Phenotypic Plasticity,” Acta Tropica, Vol. 81, No. 2, 2002, p. 101. doi:10.1016/S0001-706X(01)00200-5
[6] Z. U. Khan, S. Ahmed, E. Mokaddas and R. Chandy, “Tobacco Agar, a New Medium for Differentiating Candida dubliniensis from Candida albicans,” Journal of Clinical Microbiology, Vol. 42, No. 10, 2004, pp. 4796-4798. doi:10.1128/JCM.42.10.4796-4798.2004
[7] G. Diaz-Fuentes, C. Shin, E. R. Sy, M. Niazi and L. Menon, “Pulmonary Fungal Involvement in HIV-Positive Patients in an Inner City Hospital in New York,” The Internet Journal of Pulmonary Medicine, Vol. 7, No. 2, 2007, pp. 1531-2984.
[8] A. Usharani, M. Bharathi and C. Sandhya, “Isolation and Characterization of Candida Species from Oropharyngeal Secretions of HIV Positive Individuals,” Nasza Dermatology Online, Vol. 2, No. 3, 2011, pp. 119-124.
[9] L. Y. Binesh and M. Kalyani, “Phenotypic Characterization of Candida Species and Their Antifungal Susceptibility from a Tertiary Care Centre,” Journal of Pharmaceutical and Biomedical Sciences, Vol. 11, No. 12, 2011.
[10] C. R. Juliana, “Phenotypic and Genotypic Identification of Candida spp. Isolated from Hospitalized Patients,” Revista Iberoamericana de Micología, Vol. 21, 2004, pp. 24-26.
[11] E. W. Koneman, S. D. Allen, W. M. Janda, P. C. Schreckenberger and W. C. Winn, “The Role of Microbiology Laboratory in the Diagnosis of Infectious Disease: Guidelines to Practice and Management,” In: R. P. Pfeiffer and B. C. Magnus, Eds., Color Atlas and Text Book of Diagnostic Microbiology, 5th Edition, Lippincot Press, New York, 1997, p. 69.
[12] B. A. Forbes, D. F. Sahm and A. S. Weissfeld, “Laboratory Methods in Basic Mycology,” In: Bailey and Scott’s Diagnostic Microbiology, 11th Edition, Mosby, St. Louis, 2002, pp. 711-798.
[13] L. S. Garcia, G. W. Procop, G. D. Roberi and R. B. Thompson, “Overview of Conventional Methods for Bacterial Identification, Chapter 13,” In: B. A. Forbes, D. F. Sahm and A. S. Weissfeld, Eds., Bailey and Scott’s Diagnostic Microbialogy, 10th Edition, Mosby, 1998, pp. 167-181.
[14] M. Cheesbrough, “Medical Laboratory Manual for Tropical Countries: Microbiology Vol. 2. Butterworth-Heinemann Ltd.,” University Press, Cambridge, 1995, pp. 248-273.
[15] G. S. De Hoog, J. Guarro and M. E. Grauer, “Atlas of Clinical Fungi,” 2nd Edition, Centraalbureauvoor Schimmelcultures, Baarn, 2000.
[16] H. S. A. Aluyi, F. D. Otajevwo and O. Iweriebor, “Incidence of Pulmonary Mycoses in Patients with Acquired Immunodeficiency Diseases,” Nigerian Journal of Clinical Practice, Vol. 13, No. 1, 2010, pp. 78-83.
[17] G. St. Germain, M. Laverdiere and R. Pelletier, “Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2 Year (1996-1998) Multicentre Surveillance Study in Quebec, Canada,” Journal of Clinical Microbiology, Vol. 39, No. 3, 2001, pp. 949-953. doi:10.1128/JCM.39.3.949-953.2001
[18] P. Bhalla, “Non Mycobacterial and Bacterial Infections in HIV/AIDS,” In: U. K. Baveja and J. Sokhey, Eds., Manual on Laboratory Diagnosis of Common Opportunistic Infections Associated with HIV/AIDS, National Institute of Communicable Diseases, New Delhi, 2002, pp. 100-118.
[19] L. A. Shailaja, L. A. Pai, D. R. Mathur and V. Lakshmi, “Prevalence of Bacterial and Fungal Agents Causing Lower Respiratory Tract Infections in Patients with HIV Infection,” Indian Journal of Medical Microbiology, Vol. 22, No. 1, 2004, pp. 28-33.
[20] N. Koffi, A. Ngom, B. Kouassi and M. Tchamran, “Bacterial Lung Disease from Common Bacteria during HIV Infection in African Adults Hospitalized in Abidjan, Cote d’Ivoire,” Bulletin de la Societe de Pathologie Exotique, Vol. 90, No. 5, 1997, pp. 370-372.

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.